Wednesday, July 8, 2026

Intelligence · Clinical Development

Pipeline search results

Programs matching “nicotine” across our ClinicalTrials.gov index — phase, modality, sponsor, and trial IDs.

Matching programs 97
Total indexed 20,548
Sponsors 1,769

Quick answer

Showing 97 pipeline programs matching "nicotine" from NovaPharmaNews Clinical Development Intelligence — phase, modality, sponsor, and ClinicalTrials.gov trial IDs.

Refine search

97 results for “nicotine” Back to intelligence hub

Search results

Page 1 of 5
  1. Extended treatment

    BRIGHT MINDS BIOSCIENCES INC.

    Nicotine Dependence

    phase 3 small molecule completed

    1 trial
  2. Internet-based smoking treatment

    BRIGHT MINDS BIOSCIENCES INC.

    Nicotine Dependence

    phase 3 other completed

    1 trial
  3. Nicotine Patch

    BRIGHT MINDS BIOSCIENCES INC.

    Smoking Cessation

    phase 3 small molecule completed

    2 trials
  4. Nicotine patch

    Jasper Therapeutics

    Nicotine Dependence

    phase 3 small molecule active

    1 trial
  5. Nicotine polacrilex, Bupropion

    BRIGHT MINDS BIOSCIENCES INC.

    Tobacco Use Disorder

    phase 3 small molecule completed

    1 trial
  6. Varenicline

    BRIGHT MINDS BIOSCIENCES INC.

    Nicotine Dependence

    phase 3 small molecule completed

    6 trials
  7. Varenicline

    BRIGHT MINDS BIOSCIENCES INC.

    Nicotine Addiction

    phase 3 small molecule completed

    1 trial
  8. nicotine transdermal system

    BRIGHT MINDS BIOSCIENCES INC.

    Tobacco Use Disorder

    phase 3 small molecule completed

    2 trials
  9. tobacco abstinent contingent

    BRIGHT MINDS BIOSCIENCES INC.

    Nicotine Dependence

    phase 3 other completed

    1 trial
  10. 42 mg transdermal nicotine replacement

    BRIGHT MINDS BIOSCIENCES INC.

    Tobacco Use Disorder

    phase 2 small molecule completed

    1 trial
  11. CHRMS19-0129

    BRIGHT MINDS BIOSCIENCES INC.

    Tobacco Use Disorder

    phase 2 other completed

    1 trial
  12. Chantix

    BRIGHT MINDS BIOSCIENCES INC.

    Nicotine Dependence

    phase 2 small molecule terminated

    2 trials
  13. Cigarettes with varying nicotine content

    BRIGHT MINDS BIOSCIENCES INC.

    Tobacco Use Disorder

    phase 2 other completed

    1 trial
  14. E-cigarettes

    BRIGHT MINDS BIOSCIENCES INC.

    Nicotine Dependence

    phase 2 other completed

    1 trial
  15. EVP-6124

    BRIGHT MINDS BIOSCIENCES INC.

    Nicotine Dependence

    phase 2 small molecule terminated

    1 trial
  16. GSK598809

    BRIGHT MINDS BIOSCIENCES INC.

    Nicotine Dependence

    phase 2 small molecule completed

    1 trial
  17. GW468816

    BRIGHT MINDS BIOSCIENCES INC.

    Nicotine Dependence

    phase 2 small molecule completed

    1 trial
  18. N-acetylcysteine (NAC)

    BRIGHT MINDS BIOSCIENCES INC.

    Nicotine Dependence

    phase 2 small molecule completed

    1 trial
  19. Nicotine 0 mg/mL

    BRIGHT MINDS BIOSCIENCES INC.

    Nicotine

    phase 2 small molecule completed

    1 trial
  20. Nicotine Patch

    BRIGHT MINDS BIOSCIENCES INC.

    Tobacco Use Disorder

    phase 2 small molecule completed

    2 trials
  21. Nicotine gum and lozenge

    BRIGHT MINDS BIOSCIENCES INC.

    Nicotine Dependence

    phase 2 small molecule completed

    1 trial
  22. Nicotine replacement

    BRIGHT MINDS BIOSCIENCES INC.

    Cardiovascular Disease

    phase 2 small molecule completed

    1 trial
  23. Pre-Quit Nicotine Lozenges

    BRIGHT MINDS BIOSCIENCES INC.

    Smoking Cessation

    phase 2 small molecule completed

    1 trial
  24. Selegiline Transdermal Patch

    BRIGHT MINDS BIOSCIENCES INC.

    Nicotine Dependence

    phase 2 small molecule completed

    1 trial

Frequently asked questions

What is the Clinical Development Intelligence Platform?

It is NovaPharmaNews pipeline intelligence hub covering 20,548 clinical development programs — not just a directory. It includes phase distribution dashboards, therapeutic area overviews, NDA/BLA watchlists, upcoming readouts, company pipeline rankings, competitive landscape maps, and personalized watchlists.

How does this compare to Evaluate Pharma or Citeline?

Like Evaluate Pharma and Citeline Trialtrove, we index ClinicalTrials.gov programs by sponsor, phase, and indication. Our platform adds cross-links to NovaPharmaNews company profiles, drug INN pages, patents, and congress readout calendars — improving crawl depth and reducing orphan program pages.

Where does pipeline data come from?

Program records derive from ClinicalTrials.gov and link to sponsor company profiles. Trial status and phase reflect registry data at last sync — verify on ClinicalTrials.gov before investment decisions. See our data sources page for attribution.

Can I follow a company or program for updates?

Yes — use the watchlist forms on this page to follow sponsors, individual programs, disease clusters, or therapeutic areas. Alerts use the same subscription infrastructure as our events intelligence hub.